Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1

Publisher： Karger

E-ISSN： 1664-5464|2|1|286-297

ISSN： 1664-5464

Source： Dementia and Geriatric Cognitive Disorders Extra, Vol.2, Iss.1, 2012-08, pp. : 286-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perils and Pitfalls in the Interpretation of Clinical Trials: A Reflection on the Recent Experience in Multiple Sclerosis

By  

Neuroepidemiology, Vol. 18, Iss. 2, 1999-02 ,pp. : 53-63

Karger

Access to resources Recommend Favorite

New Approaches to Clinical Trials in Vascular Dementia: Memantine in Small Vessel Disease

By  

Cerebrovascular Diseases, Vol. 13, Iss. 2, 2002-03 ,pp. : 61-66

Karger

Access to resources Recommend Favorite

Patterns of Outcome Measurement in Parkinson’s Disease Clinical Trials

By  

Neuroepidemiology, Vol. 19, Iss. 2, 2000-02 ,pp. : 100-108

Karger

Access to resources Recommend Favorite

Clinical Validity of the Mattis Dementia Rating Scale in Differentiating Mild Cognitive Impairment in Parkinson's Disease and Normative Data

By  

Dementia and Geriatric Cognitive Disorders, Vol. 39, Iss. 5-6, 2015-03 ,pp. : 303-311

Karger

Access to resources Recommend Favorite

Meta-Analysis of Clinical Trials with Copolymer 1 in Multiple Sclerosis

By  

European Neurology, Vol. 43, Iss. 4, 2000-05 ,pp. : 189-193

Karger

Access to resources Recommend Favorite